Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE4

Conditions

Plaque Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Singapore General Hospital, Outram Park, Singapore
Contact: Study coordinator (Ying Ying Leung, MD) · katy.leung.y.y@singhealth.com.sg · +65 63265276
Contact: Principal Investigator (Ying Ying Leung, MD)

Study leads

Ying Ying Leung, MD
Principal Investigator
Singapore General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis · Overweight or Obesity

Abroad (travel likely)RecruitingPHASE4

Phoenix, United States · Fountain Valley, United States

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Fountain Valley, United States · Los Angeles, United States

Modifying PEST for Psoriatic Arthritis Screening

Plaque Psoriasis · Psoriatic Arthritis

Abroad (travel likely)Recruiting

Calgary, Canada · Edmonton, Canada

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States